169 related articles for article (PubMed ID: 8623946)
1. Growth of microorganisms in propofol, thiopental, and a 1:1 mixture of propofol and thiopental.
Crowther J; Hrazdil J; Jolly DT; Galbraith JC; Greacen M; Grace M
Anesth Analg; 1996 Mar; 82(3):475-8. PubMed ID: 8623946
[TBL] [Abstract][Full Text] [Related]
2. The growth of microorganisms in propofol and mixtures of propofol and lidocaine.
Wachowski I; Jolly DT; Hrazdil J; Galbraith JC; Greacen M; Clanachan AS
Anesth Analg; 1999 Jan; 88(1):209-12. PubMed ID: 9895094
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of bacterial growth by different mixtures of propofol and thiopentone.
Joubert KE; Picard J; Sethusa M
J S Afr Vet Assoc; 2005 Jun; 76(2):85-9. PubMed ID: 16108527
[TBL] [Abstract][Full Text] [Related]
4. A comparison of microbial growth in alfaxalone, propofol and thiopental.
Strachan FA; Mansel JC; Clutton RE
J Small Anim Pract; 2008 Apr; 49(4):186-90. PubMed ID: 18194193
[TBL] [Abstract][Full Text] [Related]
5. Growth of microorganisms in propofol and methohexital mixtures.
Harvey BR; Ganzberg S
J Oral Maxillofac Surg; 2003 Jul; 61(7):818-23. PubMed ID: 12856257
[TBL] [Abstract][Full Text] [Related]
6. The preventive effect of diphenhydramine on bacterial growth in propofol: a laboratory study.
Güzelant A; Apiliogullari S; Kara I; Turhan V; Apiliogullari B; Yilmaz H; Balasar M; Duman A
Eur J Anaesthesiol; 2008 Sep; 25(9):737-40. PubMed ID: 18471340
[TBL] [Abstract][Full Text] [Related]
7. Growth of Escherichia coli in propofol, lidocaine, and mixtures of propofol and lidocaine.
Sakuragi T; Yanagisawa K; Shirai Y; Dan K
Acta Anaesthesiol Scand; 1999 Apr; 43(4):476-9. PubMed ID: 10225084
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity of remifentanil and mixtures of remifentanil and propofol.
Apan TZ; Apan A; Sahin S; Cakirca M
J Clin Anesth; 2007 Aug; 19(5):346-50. PubMed ID: 17869984
[TBL] [Abstract][Full Text] [Related]
9. Growth of Microorganisms in Propofol and Mixture of Propofol, Lidocaine and Fentanyl.
Altan HA; Bonabi E; Kesici S; Sezer H; Ucar VB
J Coll Physicians Surg Pak; 2019 Sep; 29(9):828-832. PubMed ID: 31455476
[TBL] [Abstract][Full Text] [Related]
10. Propofol, but not thiopental, supports the growth of Candida albicans.
Sosis MB; Braverman B; Villaflor E
Anesth Analg; 1995 Jul; 81(1):132-4. PubMed ID: 7598241
[TBL] [Abstract][Full Text] [Related]
11. Growth of Staphylococcus aureus in four intravenous anesthetics.
Sosis MB; Braverman B
Anesth Analg; 1993 Oct; 77(4):766-8. PubMed ID: 8214662
[TBL] [Abstract][Full Text] [Related]
12. An experimental study on antimicrobial activity of silicone oil in vitro.
Yan H; Li J
Ophthalmologica; 2008; 222(4):245-8. PubMed ID: 18467849
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of antimicrobial properties of silicon oil--in vitro studies].
Mackiewicz J; Kozioł-Montewka M; Kosior-Jarecka E; Szczepanik A; Wójtowicz M; Zagórski Z
Klin Oczna; 2004; 106(3 Suppl):434-5. PubMed ID: 15636227
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of bacterial growth by lignocaine in propofol emulsion.
Ozer Z; Ozturk C; Altunkan AA; Cinel I; Oral U
Anaesth Intensive Care; 2002 Apr; 30(2):179-82. PubMed ID: 12002925
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous anesthetics on bacterial elimination in human blood in vitro.
Heller A; Heller S; Blecken S; Urbaschek R; Koch T
Acta Anaesthesiol Scand; 1998 May; 42(5):518-26. PubMed ID: 9605366
[TBL] [Abstract][Full Text] [Related]
16. The effect of preservatives on the sterility of microorganisms introduced into different fruit juices.
Nzeako BC; Al-Hashmi S
Med Sci Monit; 2006 May; 12(5):BR179-86. PubMed ID: 16641872
[TBL] [Abstract][Full Text] [Related]
17. Examination of antimicrobial activity of selected non-antibiotic products.
Kruszewska H; Zareba T; Tyski S
Acta Pol Pharm; 2010; 67(6):733-6. PubMed ID: 21229899
[No Abstract] [Full Text] [Related]
18. The antimicrobial effects of ketamine combined with propofol: An in vitro study.
Begec Z; Yucel A; Yakupogullari Y; Erdogan MA; Duman Y; Durmus M; Ersoy MO
Braz J Anesthesiol; 2013; 63(6):461-5. PubMed ID: 24565343
[TBL] [Abstract][Full Text] [Related]
19. Viability of selected microorganisms in parenteral preparations for novel systemic anti-cancer therapy.
Almasi J; Knoll L; Thiesen J; Krämer I
J Oncol Pharm Pract; 2024 Jun; 30(4):614-621. PubMed ID: 37272015
[TBL] [Abstract][Full Text] [Related]
20. Comparative growth dynamics of bacterial and fungal contaminants in bupivacaine liposomal injectable suspension, bupivacaine 0.5%, and propofol.
Wallace A; Love L; Gensler C; Jacob M; Robertson J; Messenger K
PLoS One; 2023; 18(2):e0281768. PubMed ID: 36795683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
